Trigger Point Injections Versus Lidocaine Patch for Myofascial Pain in the Emergency Department

Withdrawn before enrolling · Phase 4

Conditions studied: Myofascial Trigger Point Pain, Myofacial Pain

In brief

The aim of this trial is to investigate the efficacy of trigger point injections with 1% lidocaine in reducing myofascial back and neck pain in the Emergency Department compared to lidocaine patches 5%.

Key facts

Study ID

NCT05151510

Run by

University of California, Irvine

People needed

0

Starts

2021-11-01

Expected to finish

2022-06-30

Last updated by the study team

2026-02-13

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• 18 years or older
• Diagnosed with myofascial pain of the posterior neck or back. *The diagnosis of myofascial pain was based on established criteria of having a palpable taut band (trigger point) that when depressed reproduced the patient's pain.

You may not qualify if…

• midline spinal tenderness
• evidence of radiculopathy
• pregnant
• have an allergy to lidocaine
• altered or deemed incapable of making informed consent
• had signs of infection or skin breakdown over the trigger point.

Where it is running

• Emergency Room at UCI Medical Center — Orange, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.